Biomedical Research and Therapy Logo

Biomedical Research and Therapy

Oral Abstracts Open Access Logo

ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer

Van Thanh Ta 1, *

  1. Hanoi Medicine University, Hanoi, Vietnam
Correspondence to: Van Thanh Ta, Hanoi Medicine University, Hanoi, Vietnam. Email: [email protected].
Volume & Issue: Vol. 4 No. S (2017): Abstract Proceeding: International conference INNOVATIONS IN CANCER RESEARCH AND REGENERATIVE MEDICINE 2017 | Page No.: S33 | DOI: 10.15419/bmrat.v4iS.243
Published: 2017-09-05

Online metrics

Statistics from the website

  • Abstract Views: 0
  • Galley Views: 0

Statistics from Dimensions

Statistics from PlumX
Copyright © 2017 by the author(s).

Copyright The Author(s) 2024. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Keywords: cancer Non-small cell lung cancer TKI acquired resistance Secondary T790M mutation

Comments